Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
THCG Group is a Thailand-based vertically integrated medical hemp and cannabis company involved in cultivation, production, distribution, export/import, and retail operations. The company appears to operate under Thai medical-cannabis licenses and has been described as having cultivation, wellness-center, and downstream product capabilities. Publicly available information indicates THCG has partnered with Sunderstorm to commercialize Kanha-branded cannabis gummies in Thailand and international markets. THCG has also been identified as a joint-venture or partially owned affiliate of G.K. Hemp Group, a subsidiary of Gunkul Engineering, supporting its development in the regulated Thai cannabis market. The company is better characterized as a commercial cannabis operator than a traditional drug-development biotech with a disclosed clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on THCG Group.